Financhill
Back

Design Therapeutics Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
52

DSGN
Design Therapeutics

Last Price:
5.60
Seasonality Move:
-1.4%
Sell
50

DRUG
Bright Minds Biosciences

Last Price:
48.71
Seasonality Move:
-16.97%
Buy
52
Design Therapeutics (DSGN) is a Buy

Is Design Therapeutics a Buy, Sell or Hold?

  • The current Design Therapeutics [DSGN] share price is $5.65. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $28.80. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DSGN Stock Price Chart

What is Design Therapeutics's stock price today?

  • The Design Therapeutics share price today is $5.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $28.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

DSGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 59.42 Buy
Chaikin Money Flow: 68631 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.91 - 5.67) Buy
Bollinger Bands (100): (3.79 - 5.23) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.5 Buy
Relative Strength Index (14 RSI): 77.84 Buy
Chaikin Money Flow: 92732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-4.96 - 12.54) Buy
Bollinger Bands (100): (-2.76 - 6.3) Buy

DSGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.01 Buy
20-day SMA: 5.2 Buy
50-day SMA: 5 Buy
200-day SMA: 3.85 Buy
8-day EMA: 5.19 Buy
20-day EMA: 5.14 Buy
50-day EMA: 4.98 Buy
200-day EMA: 4.38 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.28 Buy
20-day SMA: 4.42 Buy
50-day SMA: 2.44 Buy
200-day SMA: 1.64 Buy
8-day EMA: 13.74 Buy
20-day EMA: 7.01 Buy
50-day EMA: 3.65 Buy
200-day EMA: 2.03 Buy

Design Therapeutics Earnings Growth & DSGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Design Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):